Yunpeng Chang
Key Laboratory Of Hormones And Development, Tianjin Key Laboratory Of Metabolic Diseases
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Erratum: Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum.
Journal: International journal of biological sciences
Published: September 23, 2024
Erratum: Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum.
Journal: International journal of biological sciences
Published: October 16, 2020
Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice.
Journal: Clinical science (London, England : 1979)
Published: June 03, 2019
Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-Ay/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes.
Journal: Diabetologia
Published: September 12, 2018
Saxagliptin regulates M1/M2 macrophage polarization via CaMKKβ/AMPK pathway to attenuate NAFLD.
Journal: Biochemical and biophysical research communications
Published: July 08, 2018
Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease.
Journal: International journal of biological sciences
Published: November 26, 2017
Triptolide prevents extracellular matrix accumulation in experimental diabetic kidney disease by targeting microRNA-137/Notch1 pathway.
Journal: Journal of cellular physiology
Published: April 26, 2017
Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway.
Journal: International journal of biological sciences
Published: April 09, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026